VOYA Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,939
| Closed | -$881K | – | 2959 |
|
|
2023
Q2 | $881K | Buy |
22,939
+4,210
| +22% | +$108K | ﹤0.01% | 1740 |
|
|
2023
Q1 | $434K | Hold |
18,729
| – | – | ﹤0.01% | 2131 |
|
|
2022
Q4 | $491K | Hold |
18,729
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q3 | $368K | Buy |
18,729
+2,311
| +14% | +$46.4K | ﹤0.01% | 2223 |
|
|
2022
Q2 | $287K | Buy |
16,418
+1,850
| +13% | +$29K | ﹤0.01% | 2199 |
|
|
2022
Q1 | $238K | Buy |
14,568
+1,529
| +12% | +$20.8K | ﹤0.01% | 2284 |
|
|
2021
Q4 | $213K | Buy |
13,039
+594
| +5% | +$8.46K | ﹤0.01% | 2476 |
|
|
2021
Q3 | $159K | Hold |
12,445
| – | – | ﹤0.01% | 2636 |
|
|
2021
Q2 | $176K | Sell |
12,445
-1,561
| -11% | -$25K | ﹤0.01% | 2642 |
|
|
2021
Q1 | $218K | Hold |
14,006
| – | – | ﹤0.01% | 2496 |
|
|
2020
Q4 | $222K | Buy |
14,006
+1,764
| +14% | +$26.6K | ﹤0.01% | 2373 |
|
|
2020
Q3 | $149K | Buy |
12,242
+7,652
| +167% | +$103K | ﹤0.01% | 2250 |
|
|
2020
Q2 | $53K | Sell |
4,590
-2,282
| -33% | -$31.5K | ﹤0.01% | 2446 |
|
|
2020
Q1 | $94K | Sell |
6,872
-1,454
| -17% | -$17.2K | ﹤0.01% | 2362 |
|
|
2019
Q4 | $49K | Buy |
8,326
+3,279
| +65% | +$17.8K | ﹤0.01% | 2643 |
|
|
2019
Q3 | $27K | Hold |
5,047
| – | – | ﹤0.01% | 2536 |
|
|
2019
Q2 | $39K | Hold |
5,047
| – | – | ﹤0.01% | 2571 |
|
|
2019
Q1 | $100K | Hold |
5,047
| – | – | ﹤0.01% | 2422 |
|
|
2018
Q4 | $67K | Hold |
5,047
| – | – | ﹤0.01% | 2458 |
|
|
2018
Q3 | $185K | Hold |
5,047
| – | – | ﹤0.01% | 2362 |
|
|
2018
Q2 | $177K | Buy |
5,047
+1,260
| +33% | +$48.3K | ﹤0.01% | 2399 |
|
|
2018
Q1 | $176K | Hold |
3,787
| – | – | ﹤0.01% | 2357 |
|
|
2017
Q4 | $142K | Hold |
3,787
| – | – | ﹤0.01% | 2436 |
|
|
2017
Q3 | $202K | Hold |
3,787
| – | – | ﹤0.01% | 2380 |
|
|
2017
Q2 | $216K | Buy |
3,787
+503
| +15% | +$25.2K | ﹤0.01% | 2370 |
|
|
2017
Q1 | $177K | Hold |
3,284
| – | – | ﹤0.01% | 2321 |
|
|
2016
Q4 | $187K | Hold |
3,284
| – | – | ﹤0.01% | 2322 |
|
|
2016
Q3 | $204 | Hold |
3,284
| – | – | ﹤0.01% | 2278 |
|
|
2016
Q2 | $186K | Buy |
+3,284
| New | +$200K | ﹤0.01% | 2298 |
|
VOYA Investment Management's KDNY Position: Q3 2023 in Review
VOYA Investment Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 22,939 shares — an estimated $881K sold.
VOYA Investment Management first reported a position in KDNY in Q2 2016 and held it in 29 quarters. The position peaked at $881K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- VOYA Investment Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- VOYA Investment Management sold 22,939 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $881K.
- VOYA Investment Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 29 quarters.
- VOYA Investment Management's Chinook Therapeutics, Inc. Common Stock position peaked at $881K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on VOYA Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.